| |
|
|
|
|
|
|
|||
|
Blood, 15 November 2007, Vol. 110, No. 10, pp. 3532-3539. Prepublished online as a Blood First Edition Paper on July 27, 2007; DOI 10.1182/blood-2007-05-091942.
Submitted May 24, 2007
Divisioin of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada * Corresponding author; email: lillian.sung{at}sickkids.ca.
The primary objective was to describe the prevalence and characteristics of microbiologically defined infections and infection-related mortality (IRM) in 492 children with acute myeloid leukemia enrolled on CCG-2961. Secondary objectives were to determine the relationship between demographic, disease-related, and therapeutic variables, and infections and IRM. Institutions documented infections prospectively. Age, ethnicity, body mass index, leukemia karyotype, treatment and institutional size were examined for association with infection outcomes. Over 60% of children experienced such infections in each of three phases of chemotherapy. There were 58 infectious deaths; cumulative incidence of IRM was 11±2%. Thirty-one percent of infectious deaths were associated with Aspergillus, 25.9% with Candida, and 15.5% with alpha haemolytic streptococci. Age over sixteen years (hazard ratio [HR] 3.32, 95% confidence interval [CI] 1.87, 5.89; P<.001), non-white ethnicity (HR 1.85, 95% CI 1.10, 3.09; P=.02) and underweight status (HR 3.06, 95% CI 1.51, 6.22; P=.002)] were associated with IRM while size of the treating institution was not. Thus, age, ethnicity and BMI were important contributors to IRM. Fungi and Gram positive cocci were the most common organisms associated with IRM and in particular, Aspergillus species was the largest contributor to infectious deaths.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||